A phase 2 dose-finding study evaluated the safety and efficacy of infigratinib, an orally bioavailable FGFR1–3 selective tyrosine kinase inhibitor,…
Leer más »Salud
New England Journal of Medicine, Ahead of Print. massmed: New England Journal of Medicine: Table of Contents
Leer más » New England Journal of Medicine, Ahead of Print. massmed: New England Journal of Medicine: Table of Contents
Leer más » New England Journal of Medicine, Ahead of Print. massmed: New England Journal of Medicine: Table of Contents
Leer más » In a randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular…
Leer más » In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American…
Leer más » In a large trial involving patients with acute myocardial infarction, 95% of whom had ST-segment elevation myocardial infarction, spironolactone did…
Leer más » New England Journal of Medicine, Ahead of Print. massmed: New England Journal of Medicine: Table of Contents
Leer más » New England Journal of Medicine, Ahead of Print. massmed: New England Journal of Medicine: Table of Contents
Leer más » New England Journal of Medicine, Ahead of Print. massmed: New England Journal of Medicine: Table of Contents
Leer más »